Gastroesophageal (GE) Junction Carcinomas Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 270 pages | ID: G8C61FEDCF4EN
VPAResearch

Abstracts

Gastroesophageal (GE) Junction Carcinomas ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Gastroesophageal (GE) Junction Carcinomas disease clinical trials. The research work analyzes the ongoing Gastroesophageal (GE) Junction Carcinomas clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Gastroesophageal (GE) Junction Carcinomas treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Gastroesophageal (GE) Junction Carcinomas clinical trials.

Scope of the Report-

• Ongoing Gastroesophageal (GE) Junction Carcinomas clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Gastroesophageal (GE) Junction Carcinomas
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Gastroesophageal (GE) Junction Carcinomas clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Gastroesophageal (GE) Junction Carcinomas Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Gastroesophageal (GE) Junction Carcinomas Trials by Phase
3.2 Ongoing Gastroesophageal (GE) Junction Carcinomas Trials by Type
3.3 Ongoing Gastroesophageal (GE) Junction Carcinomas Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Gastroesophageal (GE) Junction Carcinomas Trials
4.2 Top 10 Countries conducting Gastroesophageal (GE) Junction Carcinomas Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Gastroesophageal (GE) Junction Carcinomas Trials by Sponsor Type
5.2 Gastroesophageal (GE) Junction Carcinomas Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Gastroesophageal (GE) Junction Carcinomas Trials by year
6.2 Subjects Recruited for Gastroesophageal (GE) Junction Carcinomas Trials by Phase
6.3 Subjects Recruited for Gastroesophageal (GE) Junction Carcinomas Trials by Trial Type
6.4 Subjects Recruited for Gastroesophageal (GE) Junction Carcinomas Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Gastroesophageal (GE) Junction Carcinomas Trials- Phase
7.2 Ongoing Gastroesophageal (GE) Junction Carcinomas Trials- Phase
7.3 Ongoing Gastroesophageal (GE) Junction Carcinomas Trials- Phase
7.4 Ongoing Gastroesophageal (GE) Junction Carcinomas Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials by Country
Figure 2: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials by Phase of Development, 2018
Figure 3: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials by Status, 2018
Figure 4: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials by Type, 2018
Figure 5: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials Split by Region, 2000-2018
Figure 6: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials by Type of Economy, 2018
Figure 7: Gastroesophageal (GE) Junction Carcinomas- Enrolment by Phase, 2018
Figure 8: Gastroesophageal (GE) Junction Carcinomas- Enrolment by Trial Type, 2018
Figure 9: Gastroesophageal (GE) Junction Carcinomas- Enrolment by Recruitment Status, 2018
Figure 10: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials by Sponsor Type, 2018
Figure 11: Gastroesophageal (GE) Junction Carcinomas- Enrolment by Type of Sponsors
Figure 12: Gastroesophageal (GE) Junction Carcinomas- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials by Sponsor Type, 2018
Table 2: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials by Economy Type, 2018
Table 3: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials by Region, 2018
Table 4: Gastroesophageal (GE) Junction Carcinomas- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Gastroesophageal (GE) Junction Carcinomas- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Gastroesophageal (GE) Junction Carcinomas- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Gastroesophageal (GE) Junction Carcinomas- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Gastroesophageal (GE) Junction Carcinomas- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Gastroesophageal (GE) Junction Carcinomas- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company